{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:59:49Z","timestamp":1773802789767,"version":"3.50.1"},"reference-count":83,"publisher":"Oxford University Press (OUP)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"DOI":"10.2146\/ajhp140028","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T16:19:33Z","timestamp":1405441173000},"page":"1265-1276","source":"Crossref","is-referenced-by-count":42,"title":["Pharmacotherapy for alcoholic patients with alcoholic liver disease"],"prefix":"10.1093","volume":"71","author":[{"given":"Cynthia L.","family":"Vuittonet","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Warren Alpert Medical School, Brown University, Providence, RI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Halse","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Warren Alpert Medical School, Brown University, Providence, RI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Warren Alpert Medical School, Brown University, Providence, RI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel B.","family":"Fricchione","sequence":"additional","affiliation":[{"name":"South County Hospital, Wakefield, RI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Brickley","sequence":"additional","affiliation":[{"name":"South County Hospital, Wakefield, RI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina L.","family":"Haass-Koffler","sequence":"additional","affiliation":[{"name":"South County Hospital, Wakefield, RI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonya","family":"Tavares","sequence":"additional","affiliation":[{"name":"South County Hospital, Wakefield, RI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Swift","sequence":"additional","affiliation":[{"name":"Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, and Adjunct Associate Professor, Center for Alcohol and Addiction Studies, Brown University."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Kenna","sequence":"additional","affiliation":[{"name":"Center for Alcohol and Addiction Studies, Brown University.Center for Alcohol and Addiction Studies, Brown University, Deputy Director of Research, Providence Veterans Affairs Medical Center, Providence, RI, and Professor of Psychiatry, Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University. Center for Alcohol and Addiction Studies, and Department of Psychiatr"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041211091587800_b1-0711265","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","article-title":"Actual causes of death in the United States, 2000","volume":"291","author":"Mokdad","year":"2004","journal-title":"JAMA"},{"key":"2019041211091587800_b2-0711265","unstructured":"National Highway Traffic Safety Administration. Traffic safety facts: 2006 data. Alcohol-impaired driving. www.nrd.nhtsa.dot.gov\/Pubs\/810801.PDF (accessed 2014 Apr 28)."},{"key":"2019041211091587800_b3-0711265","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drugalcdep.2005.11.001","article-title":"The prevalence of drinking and driving in the United States, 2001\u20132002: results from the national epidemiological survey on alcohol and related conditions","volume":"83","author":"Chou","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"2019041211091587800_b4-0711265","first-page":"243","article-title":"Prevalence of DSM-IV alcohol abuse and dependence: United States, 1992","volume":"18","author":"Grant","year":"2000","journal-title":"Alcohol Health Res World"},{"key":"2019041211091587800_b5-0711265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0899-3289(94)90065-5","article-title":"Prevalence and population validity of DSM-III-R alcohol abuse and dependence: the 1989 National Longitudinal Survey on Youth","volume":"6","author":"Harford","year":"1994","journal-title":"J Subst Abuse"},{"key":"2019041211091587800_b6-0711265","doi-asserted-by":"crossref","first-page":"464","DOI":"10.15288\/jsa.1997.58.464","article-title":"Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey","volume":"58","author":"Grant","year":"1997","journal-title":"J Stud Alcohol"},{"key":"2019041211091587800_b7-0711265","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2004.02.004","article-title":"The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991\u20131992 and 2001\u20132002","volume":"74","author":"Grant","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"2019041211091587800_b8-0711265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.15288\/jsa.2001.62.211","article-title":"How effective is alcoholism treatment in the United States?","volume":"62","author":"Miller","year":"2001","journal-title":"J Stud Alcohol"},{"key":"2019041211091587800_b9-0711265","unstructured":"Harwood\n              HJ\n            \n            of The Lewin Group\n            for the National Institute on Alcohol Abuse and Alcoholism\n          . Updating estimates of the economic costs of alcohol abuse in the United States: estimates, update methods, and data (December 2000). http:\/\/pubs.niaaa.nih.gov\/publications\/economic-2000\/alcoholcost.PDF (accessed 2014 Apr 28)."},{"key":"2019041211091587800_b10-0711265","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4254\/wjh.v4.i3.81","article-title":"Alcoholic liver disease","volume":"4","author":"Bruha","year":"2012","journal-title":"World J Hepatol"},{"key":"2019041211091587800_b11-0711265","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cld.2008.07.007","article-title":"The global impact of hepatic fibrosis and end-stage liver disease","volume":"12","author":"Lim","year":"2008","journal-title":"Clin Liver Dis"},{"key":"2019041211091587800_b12-0711265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2458-12-91","article-title":"Mortality and potential years of life lost attributable to alcohol consumption in Canada in 2005","volume":"12","author":"Shield","year":"2012","journal-title":"BMC Public Health"},{"key":"2019041211091587800_b13-0711265","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1530-0277.2009.00956.x","article-title":"Understanding and treating patients with alcoholic cirrhosis: an update","volume":"33","author":"Addolorato","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"2019041211091587800_b14-0711265","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O\u2019Shea","year":"2010","journal-title":"Hepatology"},{"key":"2019041211091587800_b15-0711265","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1530-0277.1998.tb04345.x","article-title":"Gender and ethnic differences in alcohol metabolism","volume":"22","author":"Li","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"2019041211091587800_b16-0711265","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1037\/a0026996","article-title":"Drink refusal training as part of a combined behavioral intervention: effectiveness and mechanisms of change","volume":"80","author":"Witkiewitz","year":"2012","journal-title":"J Consult Clin Psychol"},{"issue":"suppl 1","key":"2019041211091587800_b17-0711265","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0168-8278(12)60005-1","article-title":"Management of alcoholic hepatitis","volume":"56","author":"Mathurin","year":"2012","journal-title":"J Hepatol"},{"key":"2019041211091587800_b18-0711265","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J Hepatol"},{"key":"2019041211091587800_b19-0711265","doi-asserted-by":"crossref","first-page":"853175","DOI":"10.1155\/2012\/853175","article-title":"Oxidative stress and inflammation: essential partners in alcoholic liver disease","volume":"2012","author":"Ambade","year":"2012","journal-title":"Int J Hepatol"},{"key":"2019041211091587800_b20-0711265","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2174\/138161211796150765","article-title":"Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review","volume":"17","author":"Edwards","year":"2011","journal-title":"Cur Pharm Design"},{"key":"2019041211091587800_b21-0711265","first-page":"161","article-title":"Alcoholic hepatitis","volume":"6","author":"Testino","year":"2013","journal-title":"J Med Life"},{"key":"2019041211091587800_b22-0711265","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1530-0277.2010.01402.x","article-title":"Management of alcoholic liver disease: an update","volume":"35","author":"Kershenobich","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"2019041211091587800_b23-0711265","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1176\/appi.ps.201000553","article-title":"Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence","volume":"63","author":"Harris","year":"2012","journal-title":"Psychiatr Serv"},{"key":"2019041211091587800_b24-0711265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-0031-1276643","article-title":"Genetics of alcoholic and nonalcoholic fatty liver disease","volume":"31","author":"Anstee","year":"2011","journal-title":"Semin Liver Dis"},{"key":"2019041211091587800_b25-0711265","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1530-0277.1981.tb04890.x","article-title":"Evidence for genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans","volume":"5","author":"Hrubec","year":"1981","journal-title":"Alcohol Clin Exp Res"},{"key":"2019041211091587800_b26-0711265","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1530-0277.2001.tb02333.x","article-title":"The critical dimension of ethnicity in liver cirrhosis mortality statistics","volume":"25","author":"Stinson","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"2019041211091587800_b27-0711265","first-page":"534","article-title":"Trends among alcohol related problems among whites, blacks, and Hispanics: 1984\u20131995","volume":"22","author":"Caetano","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"2019041211091587800_b28-0711265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9343(99)00315-0","article-title":"Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds","volume":"108","author":"Struben","year":"2000","journal-title":"Am J Med"},{"key":"2019041211091587800_b29-0711265","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/j.1572-0241.2001.04667.x","article-title":"Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease","volume":"96","author":"Willner","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2019041211091587800_b30-0711265","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1572-0241.2004.04059.x","article-title":"Ethnic differences in the prevalence of cryptogenic cirrhosis","volume":"99","author":"Browning","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"suppl 1","key":"2019041211091587800_b31-0711265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/jgh.12207","article-title":"Bermuda Triangle for the liver: alcohol, obesity, and viral hepatitis","volume":"28","author":"Zakhari","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"2019041211091587800_b32-0711265","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/jama.1984.03350140051025","article-title":"Detecting alcoholism: the CAGE questionnaire","volume":"252","author":"Ewing","year":"1984","journal-title":"JAMA"},{"key":"2019041211091587800_b33-0711265","volume-title":"The Alcohol Use Disorders Identification Test: guidelines for use in primary care","author":"Babor","year":"2001","edition":"second edition"},{"key":"2019041211091587800_b34-0711265","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cca.2006.05.001","article-title":"An enzymic test for the diagnosis of viral hepatitis: the transaminase serum activities","volume":"369","author":"De Ritis","year":"2006","journal-title":"Clin Chim Acta"},{"key":"2019041211091587800_b35-0711265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1751-2980.2010.00470.x","article-title":"Diagnosis and management of alcoholic liver disease","volume":"12","author":"McCullough","year":"2011","journal-title":"J Dig Dis"},{"key":"2019041211091587800_b36-0711265","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1572-0241.2007.01481.x","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"102","author":"Garcia-Tsao","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"2019041211091587800_b37-0711265","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2008.02.028","article-title":"Indications for liver transplantation","volume":"134","author":"O\u2019Leary","year":"2008","journal-title":"Gastroenterology"},{"key":"2019041211091587800_b38-0711265","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.3748\/wjg.v19.i36.5953","article-title":"Liver transplantation in alcoholic liver disease: current status and controversies","volume":"19","author":"Singal","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2019041211091587800_b39-0711265","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","author":"Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"2019041211091587800_b40-0711265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpgasthep0683","article-title":"Management strategies in alcoholic liver disease","volume":"4","author":"Tilg","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"2019041211091587800_b41-0711265","unstructured":"MDCalc. www.mdcalc.com (accessed 2013 Dec 26)."},{"key":"2019041211091587800_b42-0711265","unstructured":"Alcoholic hepatitis score calculator. http:\/\/potts-uk.com\/livercalculator.html (accessed 2013 Dec 26)."},{"key":"2019041211091587800_b43-0711265","first-page":"189","article-title":"Update on the management of alcoholic steatohepatitis","volume":"22","author":"Stickel","year":"2013","journal-title":"J Gastrointestin Liver Dis"},{"key":"2019041211091587800_b44-0711265","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"2019041211091587800_b45-0711265","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"2019041211091587800_b46-0711265","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"key":"2019041211091587800_b47-0711265","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2006.05.005","article-title":"Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement","volume":"4","author":"Lutchman","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019041211091587800_b48-0711265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.20012","article-title":"A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis","volume":"39","author":"Promrat","year":"2004","journal-title":"Hepatology"},{"key":"2019041211091587800_b49-0711265","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.biopsych.2010.12.010","article-title":"Activation of nuclear PPAR\u03b3 receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking","volume":"69","author":"Stopponi","year":"2011","journal-title":"Biol Psychiatry"},{"key":"2019041211091587800_b50-0711265","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"key":"2019041211091587800_b51-0711265","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"2019041211091587800_b52-0711265","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/hep.20344","article-title":"Infliximab and alcoholic hepatitis","volume":"40","author":"Mookerjee","year":"2004","journal-title":"Hepatology"},{"key":"2019041211091587800_b53-0711265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2019041211091587800_b54-0711265","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3748\/wjg.v19.i8.1158","article-title":"From fatty liver to fibrosis: a tale of \u201csecond hit\u201d","volume":"19","author":"Basaranoglu","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2019041211091587800_b55-0711265","doi-asserted-by":"crossref","first-page":"G833","DOI":"10.1152\/ajpgi.90358.2008","article-title":"Resveratrol alleviates alcoholic fatty liver in mice","volume":"295","author":"Ajmo","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2019041211091587800_b56-0711265","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/hep.23239","article-title":"Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial","volume":"50","author":"Abdelmalek","year":"2009","journal-title":"Hepatology"},{"key":"2019041211091587800_b57-0711265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A randomized placebo controlled trial of vitamin E for alcoholic hepatitis","volume":"40","author":"Mezey","year":"2004","journal-title":"J Hepatol"},{"key":"2019041211091587800_b58-0711265","first-page":"2CD002235","article-title":"S-adenosyl-L-methionine for alcoholic liver diseases","author":"Rambaldi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041211091587800_b59-0711265","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1111\/j.1572-0241.2005.00262.x","article-title":"Milk thistle for alcoholic and\/or hepatitis B or C liver diseases\u2014a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials","volume":"100","author":"Rambaldi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2019041211091587800_b60-0711265","first-page":"CD002800","article-title":"Propylthiouracil for alcoholic liver disease","volume":"6","author":"Fede","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041211091587800_b61-0711265","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/hep.1840140625","article-title":"Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial","volume":"14","author":"Bird","year":"1991","journal-title":"Hepatology"},{"key":"2019041211091587800_b62-0711265","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.1840150115","article-title":"Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial","volume":"15","author":"Trinchet","year":"1992","journal-title":"Hepatology"},{"key":"2019041211091587800_b63-0711265","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0168-8278(88)80005-9","article-title":"Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis","volume":"28","author":"Bird","year":"1998","journal-title":"J Hepatol"},{"key":"2019041211091587800_b64-0711265","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"key":"2019041211091587800_b65-0711265","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40263-013-0043-4","article-title":"Management of alcohol dependence in patients with liver disease","volume":"27","author":"Addolorato","year":"2013","journal-title":"CNS Drugs"},{"key":"2019041211091587800_b66-0711265","article-title":"Pharmacological approaches to reducing craving for alcohol in alcohol-dependent patients","author":"Haass-Koffler","journal-title":"CNS Drugs"},{"key":"2019041211091587800_b67-0711265","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-5618.2011.00973.x","article-title":"A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report","volume":"14","author":"Tolliver","year":"2012","journal-title":"Bipolar Disord"},{"key":"2019041211091587800_b68-0711265","first-page":"CD004332","article-title":"Acamprosate for alcohol dependence","volume":"9","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041211091587800_b69-0711265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"key":"2019041211091587800_b70-0711265","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"2019041211091587800_b71-0711265","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/ajhp\/61.21.2272","article-title":"Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1","volume":"61","author":"Kenna","year":"2004","journal-title":"Am J Health-Syst Pharm"},{"key":"2019041211091587800_b72-0711265","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biopsych.2012.10.020","article-title":"Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene","volume":"73","author":"Mann","year":"2013","journal-title":"Biol Psychiatry"},{"key":"2019041211091587800_b73-0711265","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.alcalc.a008160","article-title":"An open multicentric study evaluating 4 hydroxybutyric acid sodium salt (GHB) in the medium term treatment of 179 alcohol dependent patients","volume":"31","author":"Addolorato","year":"1996","journal-title":"Alcohol Alcohol"},{"key":"2019041211091587800_b74-0711265","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(05)78088-0","article-title":"Maintaining abstinence from alcohol with gamma-hydroxybutyric acid","volume":"351","author":"Addolorato","year":"1998","journal-title":"Lancet"},{"key":"2019041211091587800_b75-0711265","first-page":"CD006266","article-title":"Gammahydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses","volume":"2","author":"Leone","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041211091587800_b76-0711265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/187152710790966614","article-title":"Effectiveness and safety of baclofen in the treatment of alcohol dependent patients","volume":"9","author":"Leggio","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2019041211091587800_b77-0711265","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/alcalc\/agr017","article-title":"Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Addolorato","year":"2011","journal-title":"Alcohol Alcohol"},{"key":"2019041211091587800_b78-0711265","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","article-title":"Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"2019041211091587800_b79-0711265","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"2019041211091587800_b80-0711265","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.addbeh.2011.12.010","article-title":"Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection","volume":"37","author":"Leggio","year":"2012","journal-title":"Addict Behav"},{"key":"2019041211091587800_b81-0711265","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/phrs.2001.0883","article-title":"Metadoxine prevents damage produced by ethanol and acetaldehyde in hepatocyte and hepatic stellate cells in culture","volume":"44","author":"Guti\u00e9rrez-Ruiz","year":"2001","journal-title":"Pharmacol Res"},{"issue":"1","key":"2019041211091587800_b82-0711265","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0168-8278(98)80202-X","article-title":"Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial","volume":"28","author":"Caballer\u00eda","year":"1998","journal-title":"J Hepatol"},{"key":"2019041211091587800_b83-0711265","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hup.1244","article-title":"Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease","volume":"26","author":"Leggio","year":"2011","journal-title":"Human Psychopharm"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/71\/15\/1265\/28373050\/ajhp1265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T20:51:17Z","timestamp":1555102277000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/71\/15\/1265\/5110900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":83,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp140028","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,8,1]]},"published":{"date-parts":[[2014,8,1]]}}}